Andrew Arno - 26 Mar 2026 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Mar 2026, 17:58:11 UTC
Prior SEC filing
10 Mar 2026
Next SEC filing
15 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Arno

Key filing fact

Andrew Arno filed Form 4 for Catheter Precision, Inc. (VTAK) on 30 Mar 2026.

Key facts

  • This page summarizes Andrew Arno's Form 4 filing for Catheter Precision, Inc. (VTAK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 30 Mar 2026, 17:58.

Change

  • Previous filing in this sequence was filed on 10 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001472122 Primary reporting owner

Arno Andrew

Relationship
Director
Address
1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL
Signature
/s/ Andrew Arno
Signature date
30 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTAK transaction Derivative

Options (Right to Buy)

Award

Transaction value
Shares
+40,000
Change %
Price
$0.000000*
Shares after
40,000
Date
26 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
40,000
Exercise price
$1.15
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options vest 100% on 180 day anniversary of grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .